The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

The Foreign Corrupt Practices Act has, in just a couple of decades, become a huge revenue driver for many law firms.

President Trump's decision to pause enforcement of a law banning companies from bribing foreign government officials ...

Although President Trump can't overturn the Foreign Corrupt Practices Act, experts say he can change how it is enforced.

President Donald J. Trump signed an Executive Order pausing enforcement actions under the Foreign Corrupt Practices Act ...

President Trump has told Attorney General Pam Bondi to look at past cases by the DOJ involving the Foreign Corrupt Practices ...

The order pauses new FCPA criminal cases, directs review of existing cases, and leaves open several questions, including implications for ...

Paul Weiss attorneys and former top DOJ officials Loretta Lynch, John Carlin & Mark Mendelsohn analyze implications of AG ...

The White House claimed that the law has been a drag on U.S. business competitiveness and drained resources from both ...

The FCPA was passed in 1977 to address widespread foreign bribery by multinationals that were discovered in the wake of the ...

President Donald Trump has signed an executive order suspending enforcement of the Foreign Corrupt Practices Act (FCPA) for ...